Latency associated peptide has in vitro and in vivo immune effects independent of TGF-β1

PLoS ONE

Volumn 3, Issue 4, 2008, Pages

  Ali, Naeem A ^a,b   Gaughan, Alice A ^a,b   Orosz, Charles G ^a,b   Baran, Chris P ^a,b   McMaken, Sara ^a,b   Wang, Yijie ^a,b   Eubank, Timothy D ^a,b   Hunter, Melissa ^a,b   Lichtenberger, Frank J ^a,b   Flavahan, Nicholas A ^c   Lawler, Jack ^d   Marsh, Clay B ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; LATENCY ASSOCIATED PEPTIDE; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1; COLLAGEN; LAMININ; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; MATRIGEL; PEPTIDE; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CELL TRANSPORT; CHEMOTAXIS; COMPLEX FORMATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL MOTION; CHEMISTRY; DRUG COMBINATION; FEMALE; INFLAMMATION; LEUKOCYTE; METABOLISM; PHYSIOLOGY;

MURINAE;

ANIMALS; CELL MOVEMENT; CHEMOTAXIS; COLLAGEN; DRUG COMBINATIONS; FEMALE; INFLAMMATION; INTERLEUKIN-10; LAMININ; LATENT TGF-BETA BINDING PROTEINS; LEUKOCYTES; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MONOCYTES; PEPTIDES; PROTEOGLYCANS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 44849129542     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001914     Document Type: Article

References (36)

1. Massague J, Blain SW, Lo RS (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103: 295-309.
2. Blobe G.C, Shiemann WP, Lodish HP (2000) Role or transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358.
3. Sheppard D (2001) Integrin-Mcdiated Activation of Transforming Growth Factor-{beta}1 in Pulmonary Fibrosis. Chest 120: 19S-53.
4. Fukasawa H, Yamamoto T, Suzuki H, Togawa A, Ohashi N, et al. (2004) Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling. Kidney Int 65: 63-74.
5. Zhang Y, McCormick LL, Gilliam AC (2003) Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-venus-host disease, a model for human scleroderma. J Invest Dermatol 121: 713-719.
6. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, et al. (1993) Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 90: 770-774.
7. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
8. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, et al. (1987) Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 84: 5788-5792.
9. Postlethwaite AE, Seyer JM (1995) Idelatification of a chemotactic epitope in human transforming growth factor-beta 1 spanning amino acid residues 368-374. J Cell Physiol 161: 587-592.
10. Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFbeta activation. J Cell Sci 116: 217-224.
11. Annes JP, Chen Y, Munger JS, Rifkin DB (2004) Integrin alphaVbeta6-mediated activation of latent TGF-beta requires die latent TGF-beta binding protein-1. J Cell Biol 165: 723-734.
12. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, et al. (1999) The integrin, alpha v beta 6 binds and activates latent TGF beta.1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328.
13. Crawford SE, Stellmach V, Murphy-Ulhich JE, Ribeiro SM, Lawler J, et al. (1998) Thrombospondin-1 is a major activator of TGF-betad in vivo. Cell 93: 1159-1170.
14. Gandhi R, Anderson DE, Weiner HL (2007) Cutting Edge: Immature Human Dendritic Cells Express Latency-Associated Peptide and Inhibit T Cell Activation in a TGF-beta-Dependent Manner. J Immumol 178: 4017-4021.
15. Munger JS, Harpel JG, Giancotti FG, Rifkin DB (1998) Interactions between growth factors and integrins: latent forms oftransforming growth factor-beta are ligands for the integrin alphavbetal. Mol Biol Cell 9: 2627-2638.
16. Lu M. Munger JS, Steadele M, Busald C, Tellier M, et al. (2002) Integrin alpha8beta1 mediates adhesion to LAP-TGFbeta1. J Cell Sci 115: 4641-4648.
17. Graziano RF, Fanger MW (1987) Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J Immunol 139: 3536-3541.
18. Bickerstaff AA, VanBuskirk AM, Wakely E, Orosz CG (2000) Transforming growth factor-beta and interleukin-10 subvert alloreactive delayed type hypersensitivity in cardiac allograft acceptor mice. Transplantation 69: 1517-1520.
19. Sirak JH, Orosz CG, Wakely E, VanBuskirk AM, (1997) Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection. Transplantation 63: 1300-1307.
20. Bickerstaff AA, Wang U, Xia D, Orosz CG (2002) Allograft acceptance despite. differential strain-specific induction of TGF-beta/ II-10-mediated immunoregulation. Am J Transplant 2: 819-827.
21. Wei J, Shaw LM, Mercurio AM (1997) Integrin signaling in leukocytes: lessons from the alpha6beta1 integrin. J Leukoc Biol 61: 397-407.
22. Murphy-Ullrich JE, Poczatek M (2000) Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 11: 59-69.
23. Schultz-Cherry S, Lawler-J, Murphy-Ullrich JE (1994) The type 1 repeats of thrombospondin 1 activate latent transforming growth faclor-beta. J Biol Chem 269: 26783-26788.
24. Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, et al. (1995) Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 2. J Biol Chem 270: 7304-7310.
25. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, et al. (1999) The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 274: 13586--13593.
26. Febbraio M, Hajjar DP, Silverstein RL (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108: 785-791.
27. Ebert EC (2005) Endogenous inhibitory cytokines repress TINFalpha secretion. Cell Immunol 237: 106-114.
28. Xian, YQ, Freire-de-Lima CG, Janssen WJ, Morimoto K, Lyu et al. (2006) Oxidants selectively rEverse TGF-beta suppression of proinflammatory mediator production. J Immunol 176: 1209-1217.
29. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka SG, et al. (2000) Human allograft acceptance is associated with immune regulation. J Clin Invest 106: 145-155.
30. Janssens K, Vanhoenacker F, Bonduelle M, Verbruggen L, Van, Maldergem L, et al. (2005) Camurati-Engelmann Disease: review of the clinical, radiological and molecular data of 24 families and implications towards diagnostics and treatment. J Med Genet.
31. Janssens K, Ten Dijke P, Ralston SH, Van Hul W (2002) Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem.
32. Lawler J, Sunday M, Thibert V, Duquette M, George EL, et al. (1998) Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101: 982-992.
33. Young GD, Murphy-Ullrich JE (2004) The tryptophan-rich moths of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex. J Biol Chem 279: 47633-47642.
34. Young GD, Murphy-Ullrich JE (2004) Molecular interactions that confer latency to transforming growth factor-beta. J Biol Chem 279: 38032-38039.
35. Khalil N, Whitman C, Zoo L, Danielpour D, Greenberg A (1993) Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest 92: 1812-1818.
36. Yehualaeshet T, O'Conner R, Green-Johnson J, Mai S, Silverstein R, et al. 1999 Activation of rat lalveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol 155: 841-851.